Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOFFEE Trial
2012-005282-12Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, capecitabine in gastrointestinal cancer, hepatobiliary cancer (HBC), colorectal cancer (CRC), cancer of unknown primary (CUP), pancreatic cancer (PC), sponsored by University of Edinburgh. Started Jun 2013; status: completed.
02
Drugs
tegafurcapecitabine
03
Conditions
gastrointestinal cancerhepatobiliary cancer (HBC)colorectal cancer (CRC)cancer of unknown primary (CUP)pancreatic cancer (PC)
Beyond the preview
Go deeper on 2012-005282-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005282-12.